SCHEMBL6709884

SCHEMBL6709884

CN(c1ccc(Cl)cc1)S(=O)(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 14/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ KMT2A Q03164 1/20 0.64
▸ LMNA P02545 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ PGR P06401 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708776 0.89 SIRT2 (0.64) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL15953843 0.86 SIRT2 (0.64) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL15819635 0.86 SIRT2 (0.64) SIRT2LMNAHTTSMN1; SMN2
SCHEMBL15953307 0.86 SIRT2 (0.71) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL15821036 0.86 SIRT2 (0.60) SIRT2LMNAHTTSMN1; SMN2
SCHEMBL15953453 0.84 MAPK1 (0.69) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL12176908 0.83 LMNA (0.60) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL15953835 0.83 SIRT2 (0.66) SIRT2LMNAHTTSMN1; SMN2
SCHEMBL15819848 0.82 SIRT2 (0.80) SIRT2MEN1KMT2ALMNAHTT
SCHEMBL663317 0.82 PGR (0.61) SIRT2MEN1KMT2AHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890117-B2 Benzamide compounds and related methods of use NORTHWESTERN UNIVERSITY (US) 2018-02-13 — — US disclosed
US-20170050926-A1 Benzamide Compounds and Related Methods of Use NORTHWESTERN UNIVERSITY 2017-02-23 — — US disclosed
US-9533947-B2 Benzamide compounds and related methods of use NORTHWESTERN UNIVERSITY (US) 2017-01-03 — — US disclosed
US-9371277-B2 Benzamide compounds and related methods of use NORTHWESTERN UNIVERSITY (US) 2016-06-21 — — US disclosed
US-20150025235-A1 Benzamide Compounds and Related Methods of Use NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-22 — — US disclosed
US-20140234939-A1 Benzamide Compounds and Related Methods of Use NORTHWESTERN UNIVERSITY (US) 2014-08-21 — — US disclosed
WO-2014100833-A1 BENZAMIDE COMPOUNDS AND RELATED METHODS OF USE NORTHWESTERN UNIVERSITY (US) 2014-06-26 — — WO disclosed
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 — — US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 — — WO disclosed
WO-2001074786-A1 HETEROBIARYLSULPHONAMIDES AND THEIR USE AS PDE 7 INHIBITORS DARWIN DISCOVERY LIMITED (GB) 2001-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050926-A1 Benzamide Compounds and Related Methods of Use SIRT2, SIRT1, SIRT3 SIRT2 1/4885MEN1 2956/4885KMT2A 100/4885
US-20140234939-A1 Benzamide Compounds and Related Methods of Use SIRT2, SIRT1, SIRT3 SIRT2 1/4885MEN1 2956/4885KMT2A 100/4885
US-20150025235-A1 Benzamide Compounds and Related Methods of Use SIRT2, SIRT1, SIRT3 SIRT2 1/4885MEN1 2956/4885KMT2A 100/4885
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 SIRT2 2621/4885MEN1 4100/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback